Livio Dei Cas

Author PubWeight™ 84.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 2011 2.28
2 Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 2008 2.11
3 n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation 2011 1.71
4 Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance. Am Heart J 2003 1.67
5 The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. Cardiovasc Drugs Ther 2008 1.63
6 Prospective assessment of integrating the existing emergency medical system with automated external defibrillators fully operated by volunteers and laypersons for out-of-hospital cardiac arrest: the Brescia Early Defibrillation Study (BEDS). Eur Heart J 2005 1.52
7 Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. J Am Coll Cardiol 2002 1.49
8 High sensitivity C-reactive protein: a predictor for recurrence of atrial fibrillation after successful cardioversion. Intern Emerg Med 2009 1.44
9 Usefulness of cardiac calcification on two-dimensional echocardiography for distinguishing ischaemic from nonischaemic dilated cardiomyopathy: a preliminary report. J Cardiovasc Med (Hagerstown) 2006 1.43
10 Acute myocardial infarction in a young woman with antiphospholipid syndrome and occasional cocaine abuse. Int J Cardiol 2005 1.40
11 [Plasma brain natriuretic peptide levels in the diagnostic and prognostic assessment of patients with heart failure. Pros]. Ital Heart J 2003 1.38
12 Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol 2011 1.34
13 Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. Eur J Heart Fail 2003 1.25
14 The role of the kidney in heart failure. Eur Heart J 2012 1.16
15 Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Eur J Heart Fail 2011 1.16
16 Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis. J Am Coll Cardiol 2003 1.13
17 The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail 2007 1.08
18 The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature. Eur J Heart Fail 2004 1.05
19 Total arterial myocardial revascularization with composite grafts improves results of coronary surgery in elderly: a prospective randomized comparison with conventional coronary artery bypass surgery. Circulation 2003 1.05
20 Percutaneous coronary angioplasty in a patient with anomalous single coronary artery arising from the right sinus of Valsalva. Int J Cardiol 2006 1.05
21 Postdischarge assessment after a heart failure hospitalization: the next step forward. Circulation 2010 1.00
22 How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification. Int J Cardiol 2009 0.97
23 Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure. Cardiovasc Drugs Ther 2010 0.95
24 Off-pump coronary artery bypass surgery technique for total arterial myocardial revascularization: a prospective randomized study. Ann Thorac Surg 2003 0.91
25 Absence of inferior vena cava as a rare cause of deep venous thrombosis complicated by liver and lung embolism. Int J Cardiol 2003 0.90
26 Lack of association of coeliac disease with idiopathic and ischaemic dilated cardiomyopathies. Scand J Clin Lab Invest 2008 0.90
27 Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. Drugs 2010 0.90
28 Effect of spironolactone on left ventricular ejection fraction and volumes in patients with class I or II heart failure. Am J Cardiol 2010 0.90
29 Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study. Eur J Heart Fail 2005 0.89
30 Left internal thoracic artery-radial artery composite grafts as the technique of choice for myocardial revascularization in elderly patients: a prospective randomized evaluation. J Thorac Cardiovasc Surg 2004 0.89
31 Homocysteine and heart failure: an overview. Recent Pat Cardiovasc Drug Discov 2009 0.88
32 The 6-min walking test early after cardiac surgery. Reference values and the effects of rehabilitation programme. Eur J Cardiothorac Surg 2007 0.88
33 How should we measure left atrium size and function? J Clin Ultrasound 2012 0.87
34 Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. Int J Cardiol 2010 0.87
35 Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. Eur J Heart Fail 2007 0.86
36 Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure. J Cardiovasc Med (Hagerstown) 2011 0.86
37 Non-obstructive membranes of the left atrial appendage. Cardiovasc J Afr 2012 0.85
38 The pathophysiology of acute heart failure--it is a lot about fluid accumulation. Am Heart J 2007 0.85
39 Dynamic mild subaortic left ventricular obstruction caused by an accessory mitral valve attached to the anterior mitral valve in a young pregnant woman. Eur J Echocardiogr 2008 0.84
40 Long-term prognostic value of the right ventricular myocardial performance index compared to other indexes of right ventricular function in patients with moderate chronic heart failure. Echocardiography 2012 0.84
41 Pulmonary embolism complicated by impending paradoxical embolism - a case report and a review of literature. Kardiol Pol 2010 0.84
42 Can we prevent or treat renal dysfunction in acute heart failure? Heart Fail Rev 2012 0.83
43 Early regression of left ventricular mass associated with diastolic improvement after transcatheter aortic valve implantation. J Am Soc Echocardiogr 2012 0.83
44 Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD study. Clin Res Cardiol 2009 0.82
45 Psoriasis and cardiovascular diseases. Acta Cardiol 2010 0.82
46 A difficult diagnosis: right unilateral cardiogenic pulmonary edema. Usefulness of biochemical markers of heart failure for the correct diagnosis. Ital Heart J 2005 0.82
47 n-3 PUFAs and cardiovascular disease prevention. Future Cardiol 2010 0.82
48 Serum levels of different tumour markers in patients with chronic heart failure. Eur J Heart Fail 2005 0.81
49 Diagnosis of cor triatriatum sinister in patient with pulmonary edema and severe pulmonary arterial hypertension: assessment by three-dimensional transesophageal echocardiography. Echocardiography 2011 0.81
50 Long-term prognostic value of CA 125 serum levels in mild to moderate heart failure patients. J Card Fail 2011 0.81
51 Effects of spironolactone on long-term mortality and morbidity in patients with heart failure and mild or no symptoms. Am J Med Sci 2014 0.81
52 Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. Heart Fail Rev 2012 0.81
53 Treatment of heart failure in the elderly: never say it's too late. Eur Heart J 2009 0.80
54 Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation. Clin Res Cardiol 2012 0.80
55 A focus on antiarrhythmic properties of ranolazine. J Cardiovasc Pharmacol Ther 2012 0.79
56 CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure. Echocardiography 2008 0.79
57 One biologic marker (carbohydrate antigen-CA 125), two different diseases (ovarian cancer and congestive heart failure): practical implications of monitoring CA 125 serum levels. A case report. Ital Heart J 2003 0.79
58 Cardiological features in idiopathic inflammatory myopathies. J Cardiovasc Med (Hagerstown) 2010 0.79
59 Out-of-hospital cardiac arrest caused by transient left ventricular apical ballooning syndrome. Int J Cardiol 2007 0.79
60 Recurrent ventricular fibrillation during a febrile illness and hyperthermia in a patient with dilated cardiomyopathy and automatic implantable cardioverter defibrillator. An example of reversible electrical storm. Int J Cardiol 2005 0.79
61 Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study. Eur Heart J 2004 0.79
62 Infectious endocarditis during pregnancy, problems in the decision-making process: a case report. Cases J 2009 0.79
63 A scombroid poisoning causing a life-threatening acute pulmonary edema and coronary syndrome in a young healthy patient. Cardiovasc Toxicol 2011 0.79
64 Successful switch to sitaxsentan in a patient with HIV-related pulmonary arterial hypertension and late intolerance to nonselective endothelin receptor blockade. Ther Adv Respir Dis 2009 0.78
65 Preoperative cardiac evaluation and perioperative cardiac therapy in patients undergoing open surgery for abdominal aortic aneurysms: effects on cardiovascular outcome. Ann Vasc Surg 2012 0.78
66 Persistence of left superior vena cava, absence of coronary sinus and cerebral ictus. Int J Cardiol 2008 0.78
67 [Erythropoietin: a new perspective in cardiovascular therapy]. Monaldi Arch Chest Dis 2008 0.78
68 Pharmacokinetic and pharmacodynamic characteristics of beta-blockers: when differences may matter. J Card Fail 2006 0.78
69 Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results. Ther Clin Risk Manag 2007 0.78
70 A case report of alveolar haemorrhage associated with severe thrombocytopenia induced by abciximab infusion in a patient with an acute coronary syndrome. Intern Emerg Med 2008 0.78
71 Effects of supplementation with polyunsaturated fatty acids in patients with heart failure. Intern Emerg Med 2011 0.77
72 Endothelial damage due to air pollution. Heart Int 2006 0.76
73 Effect of short-term infusive dobutamine therapy on thyroid hormone profile and hemodynamic parameters in patients with acute worsening heart failure and low-triiodothyronine syndrome. J Investig Med 2012 0.76
74 Hemodynamic progression and outcome of asymptomatic aortic stenosis in primary care. Am J Cardiol 2011 0.76
75 [Heart rate: a risk factor or an epiphenomenon?]. G Ital Cardiol (Rome) 2010 0.76
76 Beta-blocker therapy of heart failure: an update. Expert Opin Pharmacother 2007 0.76
77 Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. Drugs 2011 0.76
78 Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus. Eur J Heart Fail 2003 0.76
79 Atrial flutter: from ECG to electroanatomical 3D mapping. Heart Int 2006 0.75
80 Sudden death prevention in heart failure: The case of CIBIS III. Heart Int 2006 0.75
81 The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia. Heart Int 2007 0.75
82 Diagnostic value of the head-up tilt test and the R-test in patients with syncope. Heart Int 2006 0.75
83 Improved graft patency rates and mid-term outcome of diabetic patients undergoing total arterial myocardial revascularization. Heart Int 2006 0.75
84 Anemia and heart failure: a cause of progression or only a consequence? Heart Int 2007 0.75
85 Endocannabinoids and cardiovascular prevention: real progress? Heart Int 2007 0.75
86 Non-compaction of the ventricular myocardium. Heart Int 2006 0.75
87 Nitric oxide and cardiovascular risk factors. Heart Int 2007 0.75
88 The study of left ventricular diastolic function by Doppler echocardiography: the essential for the clinician. Heart Int 2007 0.75
89 [Efficacy of ACE-inhibitors in patients with recent myocardial infarction. Studies with zofenopril]. G Ital Cardiol (Rome) 2012 0.75
90 Early experience with a new approach for percutaneous intervention of totally occluded saphenous vein graft: is the flow the best thrombolytic? EuroIntervention 2010 0.75
91 QT dispersion on ECG Holter monitoring and risk of ventricular arrhythmias in patients with dilated cardiomyopathy. Heart Int 2006 0.75
92 An unusual echocardiographic image of a hiatal hernia. Kardiol Pol 2011 0.75
93 Biological drugs: classic adverse effects and new clinical evidences. Cardiovasc Toxicol 2012 0.75
94 [Prognostic evaluation in patients with heart failure]. Ital Heart J Suppl 2003 0.75
95 Current guidelines in the pharmacological management of chronic heart failure. J Renin Angiotensin Aldosterone Syst 2004 0.75
96 Jugular pacing lead extraction with laser sheath: a case report. Europace 2010 0.75
97 [Infective complications in patients with implantable cardiac devices: catheter extraction]. G Ital Cardiol (Rome) 2010 0.75
98 Hypertensive crisis and acute, reversible, left ventricular systolic dysfunction: a case report. Eur J Heart Fail 2002 0.75
99 A giant interatrial mass: an unusual presentation of primary amyloidosis. Kardiol Pol 2009 0.75
100 [Insulin-resistance and cardiovascular risk]. G Ital Cardiol (Rome) 2010 0.75
101 [Undesired left ventricular pacing]. G Ital Cardiol (Rome) 2011 0.75
102 [Indications for statin therapy in patients with acute coronary syndrome of ischemic origin]. G Ital Cardiol (Rome) 2010 0.75
103 Risk factors for atrial fibrillation recurrence: a literature review. J Cardiovasc Med (Hagerstown) 2014 0.75
104 [Pharmacological therapy of chronic heart failure in the elderly]. Ital Heart J 2004 0.75
105 Secondary prevention of sudden cardiac death. Ital Heart J 2005 0.75
106 [Appropriate pharmacological therapy after surgical or percutaneous myocardial revascularization]. G Ital Cardiol (Rome) 2010 0.75
107 An echo-guided case report of rapid regression of unstable mobile thrombus aortic atheroma after aggressive statin and antiplatelet combination therapy. Am J Ther 2014 0.75
108 Is it safe to allow patients with implantable cardioverter-defibrillators to drive? Learnings from a single center experience. J Cardiovasc Med (Hagerstown) 2008 0.75
109 [Percutaneous treatment of valvular heart diseases]. G Ital Cardiol (Rome) 2012 0.75
110 The link between intracranial haemorrhage and cardiogenic shock: a case of Takotsubo cardiomyopathy. Acta Cardiol 2012 0.75
111 [Treatment of heart failure patients with inotropic drugs: beyond traditional agents]. G Ital Cardiol (Rome) 2010 0.75
112 [The study of left ventricular diastolic function by Doppler echocardiography: the essential for the clinician]. Monaldi Arch Chest Dis 2009 0.75
113 Young woman affected by a rare form of familial connective tissue disorder associated with multiple arterial pulmonary stenosis and severe pulmonary hypertension. Circ J 2008 0.75
114 Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors' Network. Kardiol Pol 2017 0.75
115 Active-fixation coronary sinus pacing lead extraction: a hybrid approach. Int J Cardiol 2011 0.75
116 [Heart failure: should treatment favor prognosis or quality of life? Opinion... in favor of prognosis]. Ital Heart J 2002 0.75
117 [Beta-blockers in the treatment of heart failure]. Ital Heart J 2005 0.75
118 Carbohydrate antigen 125: a new biomarker in heart failure. Cardiol Rev 2012 0.75
119 Clinical trials update from the World Congress of Cardiology 2006. Expert Opin Pharmacother 2007 0.75
120 A pinball game in the left atrium. Int J Cardiol 2011 0.75
121 [Chronic heart failure therapy: where we are and where we are going to]. G Ital Cardiol (Rome) 2012 0.75
122 D-dimer serum levels in a case of type B aortic dissection. A rapid test for the early diagnosis of acute aortic disease? J Cardiovasc Med (Hagerstown) 2006 0.75
123 [Role of nutrition in heart failure patients]. G Ital Cardiol (Rome) 2012 0.75
124 Biventricular pacing for patients with severe congestive heart failure: a single center experience. Ital Heart J 2002 0.75
125 Sustained torsade de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease. Int J Cardiol 2005 0.75
126 When should we use nitrates in congestive heart failure? Cardiovasc Ther 2013 0.75
127 [New pharmacological approaches to ischemic heart disease]. G Ital Cardiol (Rome) 2012 0.75